/Investor DB

Vanedge Capital Limited Partnership — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

NeuroBionicsneurobionics.ioinNov 2025

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in

Co-investorsDevice of Tomorrow CapitalDolby Family VenturesEmpath VenturesFuture VenturesGreyMatterMana Ventures+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.